Phase 3 results posted, week of November 16, 2026: 3 industry trials
Industry sponsors posted results for 3 Phase 3 trials on ClinicalTrials.gov so far in the week of November 16 to 22, 2026. Together the trials enrolled 345 participants; the largest, AstraZeneca's L-MOCA trial, enrolled 225.
Compiled by code from the stream briefs and public records linked below; no model wrote this page. How we use automation
Each line below links the stream brief and the trial's ClinicalTrials.gov record, largest trial first.
This page updates as the week's records arrive. The week ends on Sunday, November 22, 2026.
The trials
- AstraZeneca posts results of L-MOCA olaparib maintenance trial. Sponsor: AstraZeneca. Conditions: Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy, Platinum Sensitive. Intervention: Olaparib 300mg tablets. Phase: Phase 3. Enrollment: 225 (actual). Results first posted November 16, 2026. Record: NCT03534453 (L-MOCA).
- Novo Nordisk posts results of Phase 3 liraglutide trial in children with obesity. Sponsor: Novo Nordisk A/S. Condition: Obesity. Intervention: Liraglutide. Phase: Phase 3. Enrollment: 82 (actual). Results first posted November 16, 2026. Record: NCT04775082.
- Novo Nordisk posts results of Phase 3 dasiglucagon vs glucagon study in Asian adults with T1D. Sponsor: Novo Nordisk A/S. Condition: Diabetes Mellitus, Type 1. Interventions: Dasiglucagon, Glucagon. Phase: Phase 3. Enrollment: 38 (actual). Results first posted November 16, 2026. Record: NCT06588504.
By the numbers
- Trials: 3, from 2 lead sponsors.
- Participants: 345 in all across 3 trials; median 82 per trial.
- Largest: AstraZeneca's L-MOCA trial, 225. Smallest: Novo Nordisk A/S's Dasiglucagon trial, 38.
- Sponsors with more than one trial: Novo Nordisk A/S (2).
- Phases as registered: 3 Phase 3.
How this page is made
Code builds this page from the stream briefs linked above and from each trial's ClinicalTrials.gov record, read when the page was last built: sponsor, condition, intervention, phase and enrollment come from the record. No model writes this page. Registry results are summary data the sponsor posted; the record link opens them in full.